GlucoTrack Inc./$GCTK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
Ticker
$GCTK
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
11
ISIN
US45824Q7051
Website
GlucoTrack Inc. Metrics
BasicAdvanced
$3.7M
-
-$9.44
-0.14
-
Price and volume
Market cap
$3.7M
Beta
-0.14
52-week high
$0.51
52-week low
$0.12
Average daily volume
5.5M
Financial strength
Current ratio
4.849
Quick ratio
4.667
Long term debt to equity
3.128
Total debt to equity
3.61
Interest coverage (TTM)
-24.04%
Management effectiveness
Return on assets (TTM)
-161.01%
Return on equity (TTM)
-694.34%
Valuation
Price to book
0.46
Price to tangible book (TTM)
0.46
Price to free cash flow (TTM)
-0.029
Growth
Earnings per share change (TTM)
-77.25%
3-year earnings per share growth (CAGR)
-30.02%
GlucoTrack Inc. News
AllArticlesVideos
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
GlobeNewsWire·6 days ago
Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development
GlobeNewsWire·2 weeks ago
Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for GlucoTrack Inc. stock?
GlucoTrack Inc. (GCTK) has a market cap of $3.7M as of June 03, 2025.
What is the P/E ratio for GlucoTrack Inc. stock?
The price to earnings (P/E) ratio for GlucoTrack Inc. (GCTK) stock is 0 as of June 03, 2025.
Does GlucoTrack Inc. stock pay dividends?
No, GlucoTrack Inc. (GCTK) stock does not pay dividends to its shareholders as of June 03, 2025.
When is the next GlucoTrack Inc. dividend payment date?
GlucoTrack Inc. (GCTK) stock does not pay dividends to its shareholders.
What is the beta indicator for GlucoTrack Inc.?
GlucoTrack Inc. (GCTK) has a beta rating of -0.14. This means that it has an inverse relation to market volatility.